|
|
 |
|
|
|
|
News
HEMARINA and EUROBIO have entered into a distribution agreement for HEMOXCell®
HEMARINA and EUROBIO have entered into a distribution agreement for HEMOXCell®
PARIS, France – May 21th , 2013 – HEMARINA and EUROBIO, announce the signature of a commercial... More + |
HEMARINA expands its operations to Boston U.S.A. Hemarina Inc. will be the company affiliate for the America
HEMARINA, the French based Biotechnology Company, today announced its establishment in Boston, Massachusetts USA thru the incorporation of Hemarina Inc. on March 15th, 2013. The new affiliate will be... More + |
HEMARINA raises €6.3 Million in Series B Funding
This financing will help Hemarina bring to market its first product in the field of organ transplant, and will also strengthen its infrastructure as well as its R&D programs.
Morlaix,... More + |
|
|
|
Corporate
|
Technology & Products
|
Intellectual Property
|
Investors |
News & Media
|
 |
>> Company Overview
>> Managment Team
>> Board of Directors
>> Scientific and Ethics Board
>> Hemarina Label and Public Funding
|
|
>> Organ Preservation
>> Wound Healing
>> Hemoglobin Oxygen-Carrier
>> Cell Culture and Bioproduction
>> Other Perspective
|
|
>> Portfolio
>> Literature References
|
|
|
|
>> News
>> Hemarina Awards
>> Press Releases
>> Video Releases
>> 2013
|
|
|
